Clinical trial of NX 1207 in patients with liver cancer.
Phase of Trial: Phase I/II
Latest Information Update: 16 May 2012
At a glance
- Drugs Fexapotide (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors Nymox Pharmaceutical Corporation
- 16 May 2012 Nymox is still planning to conduct clinical trials of NX 1207 in patients with liver cancer.
- 01 Apr 2010 New trial record